IPC
RMD icon

Independent Portfolio Consultants’s ResMed RMD Stock Holding History

Independent Portfolio Consultants’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,570
Closed -$473K – 832
2017
Q1 		$473K Sell
6,570
-3,840
-37% -$265K 0.16% 212
2016
Q4 		$646K Sell
10,410
-1,817
-15% -$111K 0.21% 173
2016
Q3 		$792K Buy
12,227
+372
+3% +$24.8K 0.25% 131
2016
Q2 		$750K Sell
11,855
-130
-1% -$7.66K 0.24% 133
2016
Q1 		$693K Buy
11,985
+125
+1% +$7.08K 0.19% 154
2015
Q4 		$637K Buy
+11,860
New +$669K 0.19% 161

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Independent Portfolio Consultants's RMD Position: Q2 2017 in Review

Independent Portfolio Consultants sold out of ResMed (RMD) in Q2 2017, closing a stake of 6,570 shares — an estimated $473K sold.

Independent Portfolio Consultants first reported a position in RMD in Q4 2015 and held it in 6 quarters. The position peaked at $792K in Q3 2016. 340 funds tracked by Wall St. Rank hold RMD as of Q2 2017.

  • Independent Portfolio Consultants reported no remaining ResMed position as of Q2 2017 after selling out during the quarter.
  • Independent Portfolio Consultants sold 6,570 ResMed shares in Q2 2017, an estimated $473K.
  • Independent Portfolio Consultants first reported a position in ResMed in Q4 2015 and held it in 6 quarters.
  • Independent Portfolio Consultants's ResMed position peaked at $792K in Q3 2016.
  • 340 funds tracked by Wall St. Rank held ResMed as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.